Cargando…
Analgesic Efficacy of Ibuprofen and Diclofenac Potassium on Postoperative Endodontic Pain in Maxillary and Mandibular First Molars with Irreversible Pulpitis: A Randomised Controlled Trial
OBJECTIVE: The management of postoperative endodontic pain (PEP) is essential to contemporary endodontic practice. Diclofenac and ibuprofen (IBU) are two of the most widely-used non-steroidal anti-inflammatory analgesics. However, their comparative data are neither sufficient nor conclusive. This pr...
Autores principales: | Vatankhah, Mohammadreza, Zargar, Nazanin, Naseri, Mandana, Salem, Saba, Baghban, Alireza Akbarzadeh, Etemadi, Ayeh, Dianat, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098432/ https://www.ncbi.nlm.nih.gov/pubmed/37010198 http://dx.doi.org/10.14744/eej.2022.45238 |
Ejemplares similares
-
Anesthetic efficacy of supplemental buccal infiltration versus intraligamentary injection in mandibular first and second molars with irreversible pulpitis: a prospective randomized clinical trial
por: Zargar, Nazanin, et al.
Publicado: (2022) -
Analgesic Efficacy of Ketoprofen Transdermal Patch versus Ibuprofen Oral Tablet on Postendodontic Pain in Patients with Irreversible Pulpitis: A Randomized Clinical Trial
por: Zadsirjan, Saeede, et al.
Publicado: (2023) -
The Prophylactic Effects of Zintoma and Ibuprofen on Post-endodontic Pain of Molars with Irreversible Pulpitis: A Randomized Clinical Trial
por: Ramazani, Mohsen, et al.
Publicado: (2013) -
Health Technology Assessment of CEM Pulpotomy in Permanent Molars with Irreversible Pulpitis
por: Yazdani, Shahram, et al.
Publicado: (2014) -
Anaesthetic Efficacy of 4% Articaine in Comparison with 2% Lidocaine as Intraligamentary Injections after an Ineffective Inferior Alveolar Nerve Block in Mandibular Molars with Irreversible Pulpitis: A Prospective Randomised Triple-Blind Clinical Trial
por: Zargar, Nazanin, et al.
Publicado: (2021)